Sequential treatment of icotinib after first-line pemetrexed in advanced lung adenocarcinoma with unknown EGFR gene status

BACKGROUND: In non-small cell lung cancer (NSCLC), the well-developed epidermal growth factor receptor (EGFR) is an important therapeutic target. EGFR activating gene mutations have been proved strongly predictive of response to EGFR-tyrosine kinase inhibitors (TKI) in NSCLC. However, both in daily...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zheng, Yulong, Fang, Weijia, Deng, Jing, Zhao, Peng, Xu, Nong, Zhou, Jianying
Natura: Artigo
Lingua:Inglês
Pubblicazione: Pioneer Bioscience Publishing Company 2014
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120162/
https://ncbi.nlm.nih.gov/pubmed/25093093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2014.07.18
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi